Analysen von Richard Vosser
| 16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.06.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.05.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 28.05.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.05.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.05.25 | Merck Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 15.05.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 13.05.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.05.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.05.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.05.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.04.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 25.04.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 22.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 22.04.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.04.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 15.04.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 14.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.04.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 03.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.03.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 24.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 17.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 12.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.03.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.03.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.03.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 26.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 14.02.25 | Sanofi Neutral | JP Morgan Chase & Co. | |